Product NewsLife Sciences
OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel
Enables ultra-low variant detection across a range of key measurable residual disease targets in acute myeloid leukaemia, including very large FLT3-ITDs
View article